TNM AI: The Human Element in AI-Powered Cancer Staging

Lisa Ernst · 30.01.2026 · Artificial Intelligence · 7 min

As a writer, I find myself continually reflecting on the evolving landscape of information and creation. The rise of artificial intelligence, particularly large language models, has sparked a fascinating debate about authorship and the very essence of human expression. This discussion extends beyond creative arts into critical fields like medicine, where human oversight and specialized knowledge remain paramount, even as AI tools promise significant advancements.

Source: Own illustration

The TNM system (Tumor-Node-Metastasis) serves as the cornerstone of cancer staging in modern oncology. This precise classification method helps doctors determine how far cancer has spread and guides treatment decisions. While TNM provides vital prognostic information, the histopathological grading process can be surprisingly subjective, often leading to different interpretations among pathologists. These skilled specialists spend years mastering the intricate process of analyzing tissue samples, combining their extensive training with careful attention to subtle tissue changes.

Quick Summary

• The term "TNM AI" is not a widely established academic concept as of January 2026.
• TNM (Tumor-Node-Metastasis) is the standard cancer staging system.
• AI is increasingly used in pathology to improve diagnosis, prognosis, and treatment prediction.
• AI approaches in pathology include both domain-inspired (e.g., cell nucleus shape) and deep learning methods.
• Big Bird-TEN (BB-TEN) is an AI-powered natural language processing tool designed to enhance TNM staging efficiency by extracting data from pathology reports.
• AI in pathology faces challenges in clinical validation, interpretability, and cost reimbursement.
• While AI excels at pattern recognition, human expertise, ethical judgment, and nuanced interpretation remain crucial in medicine.

AI in Pathological Analysis and TNM Staging

Recent years have seen artificial intelligence emerge as a powerful ally in pathology labs worldwide. AI systems are being developed to complement traditional TNM staging by detecting subtle patterns in medical images and matching them against vast databases of known disease signatures. These AI approaches take two main forms: carefully designed systems that look for specific cellular features like nucleus shape, and more flexible deep learning models that learn directly from annotated examples with minimal human guidance.

Digital pathology enhanced by AI shows particular promise in predicting disease outcomes, identifying molecular changes in tumors, and anticipating how patients might respond to different treatments. As more pathology departments transition to digital systems, AI tools could help speed up analysis and make diagnoses more objective. However, several hurdles remain before widespread adoption becomes reality: technical challenges, substantial costs, and perhaps most importantly, the "black box" nature of AI decision-making that makes many healthcare professionals hesitant.

A notable breakthrough in this field is Big Bird-TEN (BB-TEN), an innovative natural language processing tool. This AI system tackles a persistent challenge in oncology: extracting crucial TNM staging information that often lies buried within doctors' notes and free-text fields in electronic health records. According to

The development of BB-TEN involved extensive training using 9,523 pathology reports from The Cancer Genome Atlas (TCGA). These reports were meticulously categorized to identify three key TNM elements: tumor size (6,887 reports), lymph node involvement (5,678 reports), and metastases (4,608 reports). When tested, the optimized BB-TEN model achieved remarkable accuracy, with AU-ROC values between 0.82 and 0.96, demonstrating its potential to streamline this crucial diagnostic process.

The Nuance of Human Authorship versus AI

While specialized tools like BB-TEN show impressive capabilities in focused medical tasks, the broader implications of AI in complex communication continue to spark debate. ChatGPT, OpenAI's large language model released in November 2022, has become a lightning rod for discussions about AI's role in generating sophisticated text, as noted in recent

Source: escueladeinternet.com

ChatGPT exemplifies how large language models are transforming text generation while raising important questions about authorship and originality.

The rise of AI writing tools has forced academia to confront fundamental questions about authorship, originality, and intellectual integrity. Traditional academic writing embodies more than just information transfer—it represents personal insight, critical analysis, and a distinctive scholarly voice. These elements shape how researchers present their findings, construct arguments, and engage with their audience. The individual voice in academic writing emerges through unique combinations of vocabulary choices, sentence patterns, and argumentative approaches, all reflecting the author’s deep engagement with their subject matter.

Research has shown that ChatGPT-3.5 struggles with nuanced literary analysis, often producing superficial content lacking proper citations and depth. While ChatGPT-4 shows improvements when given careful prompting, it still faces challenges with accurate quotations and source attribution. Interestingly, AI-generated texts tend to use "I" more frequently in introductions, creating a direct but potentially simplistic voice, while human students often prefer the more academically accepted "we" and "our" to maintain scholarly distance.

Source: builtin.com

The latest AI models like ChatGPT-4 show improved capabilities but still struggle with nuanced academic writing and accurate source attribution.

Recent findings from Bašić and colleagues reveal an unexpected truth: ChatGPT-3 didn't significantly enhance essay quality or writing efficiency. In fact, students writing independently slightly outperformed those using AI assistance, possibly because they avoided the pitfalls of over-reliance on the tool. These results highlight that while AI can generate readable content, it cannot yet match the depth and originality of human academic writing. The tendency toward generic language and lack of genuine authorial voice in AI-generated text risks undermining the authenticity of student work. This reality pushes educators to develop new strategies that encourage genuine writing skills while acknowledging AI's growing presence in academic environments.

AI in Clinical Practice: Opportunities and Challenges

The integration of AI in clinical settings, particularly for tasks like TNM staging, presents both significant opportunities and notable challenges.

Conclusion

While "TNM AI" hasn't emerged as a formal field by January 2026, AI's role in cancer staging continues to evolve, particularly through tools like BB-TEN. These developments promise enhanced efficiency and consistency in medical diagnosis. Yet, much like the limitations revealed in AI-generated academic writing, the irreplaceable human element in TNM staging becomes increasingly clear. AI excels at pattern recognition and data processing, but the complex reasoning, ethical judgment, and patient-specific insights that characterize medical decision-making remain distinctly human capabilities. The future likely holds a collaborative partnership: AI tools supporting and informing human specialists, creating a system that maintains diagnostic excellence while preserving essential human expertise.

Frequently Asked Questions (FAQ)